The use of prostate-specific antigen (PSA) for the monitoring of radiation therapy in prostate cancer.

MLA

Schäfer, U., et al. “The Use of Prostate-Specific Antigen (PSA) for the Monitoring of Radiation Therapy in Prostate Cancer.” Anticancer Research, vol. 17, no. 4B, July 1997, pp. 2983–86. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9329581&authtype=sso&custid=ns315887.

APA

Schäfer, U., Micke, O., Hampel, G., Brandt, B., Bovenschulte, A., Semjonow, A., & Willich, N. (1997). The use of prostate-specific antigen (PSA) for the monitoring of radiation therapy in prostate cancer. Anticancer Research, 17(4B), 2983–2986.

Chicago

Schäfer, U, O Micke, G Hampel, B Brandt, A Bovenschulte, A Semjonow, and N Willich. 1997. “The Use of Prostate-Specific Antigen (PSA) for the Monitoring of Radiation Therapy in Prostate Cancer.” Anticancer Research 17 (4B): 2983–86. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9329581&authtype=sso&custid=ns315887.